EUCTR2005-000012-27-BE进行中（未招募）不适用
Pharmacokinetic interactions between probenecid and the combination mycophenolate mofetil - cyclosporine/tacrolimus in stable renal allograft recipients
Department of Nephrology and Renal Transplantation0 个研究点目标入组 12 人开始时间: 2005年10月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •stable renal transplant recipients treated with mycophenolate mofetil and tacrolimus
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- use of other immunosuppressive drug therapy
- •- use of durgs known to interact with rifampicin
- •- combined organ transplants
- •- documented non-compliance
- •- acute rejection in the last 3 months
- •- severely impaired renal function
- •- hypoalbuminemia
- •- liver disease
- •- chronic diarrhea
- •- pregnancy
- •- fertile female patients of childbearing age
研究者
相似试验
暂停
1 期
Effect of probenecid on the pharmacokinetics of cefalexin in childreantibiotic pharmacokineticsInfection - Other infectious diseasesACTRN12619000959178A/Prof Tony Walls18
进行中（未招募）
1 期
Observational study of the effects of probenecid on the metabolism and working mechanism of sorafenib (PROSORA-study)patients with unresectable hepatocellular cancer, advanced clear-cell renal cell carcinoma, locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.EUCTR2017-002470-40-NLErasmus MC Cancer Institute16
已完成
不适用
Optimising the treatment of goutThe effectiveness of the co-administration of allopurinol and probenecid in patients with goutMetabolic and Endocrine - Other inflammatory or immune system disordersACTRN12607000247471Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital Sydney Ltd50
已完成
2 期
An intervention study of the effects of probenecid on the pharmacokinetics and pharmacodynamics of sorafenib (PROSORA-study)Hepatocellular carcinomadifferentiated thyroid carcinomametastatic renal cell carcinoma10019815NL-OMON46801Erasmus MC, Universitair Medisch Centrum Rotterdam16
已完成
不适用
The influence of probenecid on the metabolism of sorafenibHepatocellular carcinomathyroid carcinomarenal cell carcinoma HCC, hepatocellulair carcinoomRCC, NiercelcarcinoomSchildkliercarcinoomNL-OMON21261Erasmus MC16